| Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes AV Biankin, N Waddell, KS Kassahn, MC Gingras, LB Muthuswamy, ... Nature 491 (7424), 399-405, 2012 | 2229 | 2012 |
| Somatic mutation of CDKN1B in small intestine neuroendocrine tumors JM Francis, A Kiezun, AH Ramos, S Serra, CS Pedamallu, ZR Qian, ... Nature genetics 45 (12), 1483-1486, 2013 | 353 | 2013 |
| Association of distinct mutational signatures with correlates of increased immune activity in pancreatic ductal adenocarcinoma AA Connor, RE Denroche, GH Jang, L Timms, SN Kalimuthu, I Selander, ... JAMA oncology 3 (6), 774-783, 2017 | 261 | 2017 |
| Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial TL Stockley, AM Oza, HK Berman, NB Leighl, JJ Knox, FA Shepherd, ... Genome medicine 8, 1-12, 2016 | 250 | 2016 |
| The use of cytokeratin 19 (CK19) immunohistochemistry in lesions of the pancreas, gastrointestinal tract, and liver R Jain, S Fischer, S Serra, R Chetty Applied Immunohistochemistry & Molecular Morphology 18 (1), 9-15, 2010 | 204 | 2010 |
| A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors MJ Alvarez, PS Subramaniam, LH Tang, A Grunn, M Aburi, G Rieckhof, ... Nature genetics 50 (7), 979-989, 2018 | 199 | 2018 |
| Prognostic impact of novel molecular subtypes of small intestinal neuroendocrine tumor A Karpathakis, H Dibra, C Pipinikas, A Feber, T Morris, J Francis, D Oukrif, ... Clinical Cancer Research 22 (1), 250-258, 2016 | 193 | 2016 |
| Integration of genomic and transcriptional features in pancreatic cancer reveals increased cell cycle progression in metastases AA Connor, RE Denroche, GH Jang, M Lemire, A Zhang, ... Cancer cell 35 (2), 267-282. e7, 2019 | 184 | 2019 |
| An approach to duodenal biopsies S Serra, PA Jani Journal of clinical pathology 59 (11), 1133-1150, 2006 | 176 | 2006 |
| Validation of biomarkers that complement CA19. 9 in detecting early pancreatic cancer A Chan, I Prassas, A Dimitromanolakis, RE Brand, S Serra, EP Diamandis, ... Clinical Cancer Research 20 (22), 5787-5795, 2014 | 148 | 2014 |
| Heterogenous loss of mismatch repair (MMR) protein expression: a challenge for immunohistochemical interpretation and microsatellite instability (MSI) evaluation AJ McCarthy, JM Capo‐Chichi, T Spence, S Grenier, T Stockley, ... The Journal of Pathology: Clinical Research 5 (2), 115-129, 2019 | 132 | 2019 |
| Feasibility and benefits of second-line chemotherapy in advanced biliary tract cancer: a large retrospective study T Walter, AM Horgan, M McNamara, L McKeever, T Min, D Hedley, ... European Journal of Cancer 49 (2), 329-335, 2013 | 132 | 2013 |
| p16 S Serra, R Chetty Journal of clinical pathology 71 (10), 853-858, 2018 | 129 | 2018 |
| Inhibition of the sodium potassium adenosine triphosphatase pump sensitizes cancer cells to anoikis and prevents distant tumor formation CD Simpson, IA Mawji, K Anyiwe, MA Williams, X Wang, AL Venugopal, ... Cancer research 69 (7), 2739-2747, 2009 | 120 | 2009 |
| International study group on rectal cancer regression grading: interobserver variability with commonly used regression grading systems R Chetty, P Gill, D Govender, A Bateman, HJ Chang, V Deshpande, ... Human pathology 43 (11), 1917-1923, 2012 | 117 | 2012 |
| Revision 2: an immunohistochemical approach and evaluation of solid pseudopapillary tumour of the pancreas S Serra, R Chetty Journal of clinical pathology 61 (11), 1153-1159, 2008 | 103 | 2008 |
| Tumor budding is an independent adverse prognostic factor in pancreatic ductal adenocarcinoma K O’Connor, HH Li-Chang, SE Kalloger, RD Peixoto, DL Webber, ... The American journal of surgical pathology 39 (4), 472-478, 2015 | 102 | 2015 |
| Mutational signatures in esophageal squamous cell carcinoma from eight countries with varying incidence S Moody, S Senkin, SMA Islam, J Wang, D Nasrollahzadeh, ... Nature genetics 53 (11), 1553-1563, 2021 | 97 | 2021 |
| E‐cadherin can limit the transforming properties of activating β‐catenin mutations DJ Huels, RA Ridgway, S Radulescu, M Leushacke, AD Campbell, ... The EMBO journal 34 (18), 2321-2333, 2015 | 94 | 2015 |
| Nuclear E-cadherin immunoexpression: from biology to potential applications in diagnostic pathology R Chetty, S Serra Advances in anatomic pathology 15 (4), 234-240, 2008 | 93 | 2008 |
Runjan ChettyProfessor of Pathology, Chief Medical Officer Deciphex/DiagnexiaVerified email at deciphex.com
